We are live on
!
Find out more
IIM
INTECH Investment Management Portfolio holdings
AUM
$10.2B
1-Year Est. Return
28.14%
This Fund
S&P 500
This Quarter
Est. Return
+15.26%
1 Year Est. Return
+28.14%
3 Year Est. Return
+94.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.7B
AUM Growth
+$949M
(+9.8%)
Cap. Flow
-$119M
Cap. Flow
% of AUM
-1.12%
Top 10 Holdings %
Top 10 Hldgs %
26.63%
Holding
2,728
New
207
Increased
842
Reduced
1,314
Closed
281
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Targa Resources
TRGP
|
+$34M |
| 2 |
General Motors
GM
|
+$28.5M |
| 3 |
FedEx
FDX
|
+$26.3M |
| 4 |
CBRE Group
CBRE
|
+$25.4M |
| 5 |
UnitedHealth
UNH
|
+$22.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$38M |
| 2 |
DexCom
DXCM
|
+$32.3M |
| 3 |
Iron Mountain
IRM
|
+$29.5M |
| 4 |
Walt Disney
DIS
|
+$19.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$18.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.59% |
| 2 | Financials | 13.46% |
| 3 | Consumer Discretionary | 12.31% |
| 4 | Healthcare | 10.42% |
| 5 | Industrials | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Aura Biosciences
AURA
$826M
| $129K | ﹤0.01% |
20,585
-5,154
| -20% | -$30.1K |
|
2227
Viemed Healthcare
VMD
$371M
| $129K | ﹤0.01% |
18,612
+2,349
| +14% | +$15.9K |
|
2228
Sky Harbour Group
SKYH
$386M
| $128K | ﹤0.01% |
+13,144
| New | +$142K |
|
|
ZBIO
2229
Zenas BioPharma
ZBIO
$2.05B
| $128K | ﹤0.01% |
13,206
+1,607
| +14% | +$15.7K |
|
2230
Inspired Entertainment
INSE
$175M
| $127K | ﹤0.01% |
15,599
-233
| -1% | -$1.8K |
|
2231
Annexon
ANNX
$886M
| $126K | ﹤0.01% |
52,699
-14,566
| -22% | -$29.2K |
|
|
EB
2232
DELISTED
Eventbrite
EB
| $126K | ﹤0.01% |
48,033
-3,810
| -7% | -$8.78K |
|
2233
Playtika
PLTK
$1.12B
| $126K | ﹤0.01% |
+26,639
| New | +$131K |
|
|
ONTF
2234
DELISTED
ON24
ONTF
| $125K | ﹤0.01% |
23,042
+4,809
| +26% | +$24.7K |
|
2235
Asure Software
ASUR
$250M
| $125K | ﹤0.01% |
12,776
-2,477
| -16% | -$23.9K |
|
2236
American Coastal Insurance
ACIC
$493M
| $124K | ﹤0.01% |
11,122
-3,057
| -22% | -$33.7K |
|
|
ACRE
2237
Ares Commercial Real Estate
ACRE
$270M
| $124K | ﹤0.01% |
25,919
-6,198
| -19% | -$27.5K |
|
|
ZIMV
2238
DELISTED
ZimVie
ZIMV
| $123K | ﹤0.01% |
13,139
-4,902
| -27% | -$44.8K |
|
2239
908 Devices
MASS
$364M
| $123K | ﹤0.01% |
+17,187
| New | +$95.5K |
|
2240
Rocket Pharmaceuticals
RCKT
$394M
| $122K | ﹤0.01% |
49,990
+1,272
| +3% | +$6.44K |
|
2241
Vanda Pharmaceuticals
VNDA
$302M
| $122K | ﹤0.01% |
25,763
-11,368
| -31% | -$49.7K |
|
2242
Cerus
CERS
$474M
| $121K | ﹤0.01% |
85,988
-66,642
| -44% | -$88.9K |
|
2243
Kopin
KOPN
$791M
| $121K | ﹤0.01% |
+79,190
| New | +$103K |
|
|
ESPR
2244
DELISTED
Esperion Therapeutics
ESPR
| $121K | ﹤0.01% |
123,040
+28,695
| +30% | +$28.7K |
|
2245
Gossamer Bio
GOSS
$87M
| $121K | ﹤0.01% |
+98,303
| New | +$107K |
|
2246
8x8 Inc
EGHT
$332M
| $121K | ﹤0.01% |
61,657
+508
| +0.8% | +$897 |
|
2247
Candel Therapeutics
CADL
$776M
| $121K | ﹤0.01% |
23,871
-4,695
| -16% | -$24.2K |
|
2248
E.W. Scripps
SSP
$304M
| $120K | ﹤0.01% |
40,853
+21,842
| +115% | +$52.8K |
|
2249
Satellogic
SATL
$849M
| $120K | ﹤0.01% |
+33,068
| New | +$125K |
|
2250
Abeona Therapeutics
ABEO
$413M
| $120K | ﹤0.01% |
+21,049
| New | +$120K |
|
Similar funds
ACA
GI
VPIM
RA
RI
HRCM
WAM
HI
INTECH Investment Management's Q2 2025 Portfolio in Review
As of Q2 2025, INTECH Investment Management held 2,728 positions worth $10.7B, up 9.8% from $9.7B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
INTECH Investment Management's Q2 2025 filing shows 207 new, 842 increased, 1,314 reduced and 281 closed positions. Its largest new stake was Magna International: 279,080 shares worth $10.8M. The largest sale was Merck, an estimated $38M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.
- INTECH Investment Management's largest Q2 2025 buy was Magna International: 279,080 shares worth $10.8M.
- INTECH Investment Management added most to Targa Resources in Q2 2025, an estimated $34M increase.
- INTECH Investment Management's biggest Q2 2025 reduction was Merck, cutting an estimated $38M.
- INTECH Investment Management fully exited Insmed in Q2 2025, selling an estimated $7.78M.
- INTECH Investment Management's ten largest holdings make up 27% of its $10.7B portfolio in Q2 2025.
- INTECH Investment Management opened 207 new positions and closed 281 in Q2 2025.
- INTECH Investment Management's portfolio value rose 9.8% quarter-over-quarter to $10.7B.
Based on INTECH Investment Management's 13F filing for Q2 2025, filed 8 Aug 2025.